Copyright
©The Author(s) 2021.
World J Clin Cases. Jun 6, 2021; 9(16): 3951-3959
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.3951
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.3951
Immunology | Patient | Normal |
Rheumatoid factor | 158.00 IU/mL | 0 - 20 IU/mL |
SS-A antibody | > 400.00 RU/mL | 0 - 20 RU/mL |
Ro-52 antibody | > 400.00 RU/mL | 0 - 20 RU/mL |
SS-B antibody | > 400.00 RU/mL | 0 - 20 RU/mL |
AQP4 antibody IgG | 1:320 | Negative |
MOG antibody IgG | 1:32 | Negative |
MBP antibody IgG | Negative | Negative |
- Citation: Wang XJ, Xia P, Yang T, Cheng K, Chen AL, Li XP. Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report. World J Clin Cases 2021; 9(16): 3951-3959
- URL: https://www.wjgnet.com/2307-8960/full/v9/i16/3951.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i16.3951